Kurt Stoeckli

FAQ About Kurt Stoeckli

• What is Kurt Stoeckli's address?

  Kurt Stoeckli is located at
  Basel, Basel, Switzerland

• What is Kurt Stoeckli's job title?

  Kurt Stoeckli is a
  Passionate about healthcare innovation and profoundly interested in transformative and affordable medicines. I am engaged in advising life sciences companies to develop innovative and differentiating assets that address unmet medical needs and provide value to the benefit of patients. Entrepreneurial scientist and seasoned C-level executive in international life sciences industry and biopharma. Business acumen and relevant accomplishments at pre-clinical and clinical stages, up until submission and approval of products. Result-driven leader familiar with key scientific, medical, technical, regulatory and commercial success factors in the healthcare sector. Track record in discovery, clinical and technical development of innovative medicines for treatment of immune-mediated diseases (auto-immunity, immuno-oncology). Scientific background in immunology, biotechnology and chemistry (Basel, Max-Planck Munich, UCSF Medical Center, ETH Zurich). Executive programs at Harvard Business School, INSEAD and IMD. Doer profile with 25+ years of hands-on experience in running innovative product pipelines (ranging from early discovery through phase 3 support and marketed products) including biopharmaceuticals and small molecule therapeutics. Management of large multi-site units and breakthrough collaborative networks between biopharma and biotech/academia. Key assignments (1) President of Advisory Board, NDA Group AB, Sweden based in Basel, Switzerland (2) President and CSO of Glenmark Pharmaceuticals S.A., in Lausanne & Neuchâtel, Switzerland (3) Division Head of Global Biotherapeutics across all Disease Areas at SANOFI - based in Paris, France (4) Global TA Head for Immunology and Inflammation at SANOFI, Paris, France (5) Global program head at Novartis AG, Basel, Switzerland Kurt’s passion is to actively drive therapeutic innovation in healthcare, and the ongoing transformation process of current therapy concepts towards more personalised and digitalised medicine. Kurt is a healthcare advisor at present, engaged in key mandates with distinct value proposition to healthcare partners including developers of innovative medicines, payers and regulators. Nda Regulatory Service

• What industry does Kurt Stoeckli currently work in?

  Kurt Stoeckli currently works in the
  Nda Regulatory Service

• What is Kurt Stoeckli's area of expertise?

  Kurt Stoeckli specializes in
  Passionate about healthcare innovation and profoundly interested in transformative and affordable medicines. I am engaged in advising life sciences companies to develop innovative and differentiating assets that address unmet medical needs and provide value to the benefit of patients. Entrepreneurial scientist and seasoned C-level executive in international life sciences industry and biopharma. Business acumen and relevant accomplishments at pre-clinical and clinical stages, up until submission and approval of products. Result-driven leader familiar with key scientific, medical, technical, regulatory and commercial success factors in the healthcare sector. Track record in discovery, clinical and technical development of innovative medicines for treatment of immune-mediated diseases (auto-immunity, immuno-oncology). Scientific background in immunology, biotechnology and chemistry (Basel, Max-Planck Munich, UCSF Medical Center, ETH Zurich). Executive programs at Harvard Business School, INSEAD and IMD. Doer profile with 25+ years of hands-on experience in running innovative product pipelines (ranging from early discovery through phase 3 support and marketed products) including biopharmaceuticals and small molecule therapeutics. Management of large multi-site units and breakthrough collaborative networks between biopharma and biotech/academia. Key assignments (1) President of Advisory Board, NDA Group AB, Sweden based in Basel, Switzerland (2) President and CSO of Glenmark Pharmaceuticals S.A., in Lausanne & Neuchâtel, Switzerland (3) Division Head of Global Biotherapeutics across all Disease Areas at SANOFI - based in Paris, France (4) Global TA Head for Immunology and Inflammation at SANOFI, Paris, France (5) Global program head at Novartis AG, Basel, Switzerland Kurt’s passion is to actively drive therapeutic innovation in healthcare, and the ongoing transformation process of current therapy concepts towards more personalised and digitalised medicine. Kurt is a healthcare advisor at present, engaged in key mandates with distinct value proposition to healthcare partners including developers of innovative medicines, payers and regulators.

• Which languages does Kurt Stoeckli speak? 

  Kurt Stoeckli speaks the following languages:
  No languages available.

• Which industries has Kurt Stoeckli previously worked in?   

  Kurt Stoeckli has prior experience in the following industries:
  Vectorbiopharma , Nda , Nda , Glenmark Pharmaceuticals , Sanofi , Sanofi , Sanofi , Sanofi , Sanofi , Novartis

• What is Kurt Stoeckli’s work experience?  

  Kurt Stoeckli has the following professional experience:
  Nda Regulatory Service , Vectorbiopharma , Nda , Reiwa Life Sciences Consulting , Nda , Glenmark Pharmaceuticals , Sanofi , Sanofi , Sanofi , Sanofi , Sanofi , Novartis .

• How can I find Kurt Stoeckli on LinkedIn?  

  You can view Kurt Stoeckli’s
  LinkedIn profile at LinkedIn URL.

• What are Kurt Stoeckli’s work email addresses?  

  Kurt Stoeckli’s work email addresses are
  [email protected] .

• What company does Kurt Stoeckli work for?  

  Kurt Stoeckli works at
  Nda Regulatory Service